Evidence map›Paper›PMID 38383731›Full record

ArticleScientific reports2024

Haplotype information of large neuromuscular disease genes provided by linked-read sequencing has a potential to increase diagnostic yield.

Johanna Lehtonen, Anna-Maija Sulonen, Henrikki Almusa, Vilma-Lotta Lehtokari, Mridul Johari, Aino Palva, Anna H Hakonen, Kirmo Wartiovaara, Anna-Elina Lehesjoki, Bjarne Udd and 4 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 3 countries.

Johanna LehtonenCentre for Molecular Medicine Norway (NCMM), University of Oslo, Oslo, Norway.
Anna-Maija SulonenInstitute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.
Henrikki AlmusaInstitute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.
Vilma-Lotta LehtokariFolkhälsan Research Center, Folkhälsan Institute of Genetics, Helsinki, Finland.
Mridul JohariFolkhälsan Research Center, Folkhälsan Institute of Genetics, Helsinki, Finland.
Aino PalvaInstitute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.
Anna H HakonenClinical Genetics, Helsinki University Hospital, Helsinki, Finland.
Kirmo WartiovaaraClinical Genetics, Helsinki University Hospital, Helsinki, Finland.
Anna-Elina LehesjokiFolkhälsan Research Center, Folkhälsan Institute of Genetics, Helsinki, Finland.
Bjarne UddFolkhälsan Research Center, Folkhälsan Institute of Genetics, Helsinki, Finland.
Carina Wallgren-PetterssonFolkhälsan Research Center, Folkhälsan Institute of Genetics, Helsinki, Finland.
Katarina PelinFolkhälsan Research Center, Folkhälsan Institute of Genetics, Helsinki, Finland.
Marco SavareseFolkhälsan Research Center, Folkhälsan Institute of Genetics, Helsinki, Finland.
Janna SaarelaCentre for Molecular Medicine Norway (NCMM), University of Oslo, Oslo, Norway. j.s.saarela@ncmm.uio.no.
Folkhälsans Forskningscentrum · FIUniversity of Helsinki · FIHelsinki University Hospital · FIInstitute for Molecular Medicine Finland · FIOslo University Hospital · NO

Funding

NordForsk 96782The Research Council of Norway 187615
6 · The paper itself

Abstract

Rare or novel missense variants in large genes such as TTN and NEB are frequent in the general population, which hampers the interpretation of putative disease-causing biallelic variants in patients with sporadic neuromuscular disorders. Often, when the first initial genetic analysis is performed, the reconstructed haplotype, i.e. phasing information of the variants is missing. Segregation analysis increases the diagnostic turnaround time and is not always possible if samples from family members are lacking. To overcome this difficulty, we investigated how well the linked-read technology succeeded to phase variants in these large genes, and whether it improved the identification of structural variants. Linked-read sequencing data of nemaline myopathy, distal myopathy, and proximal myopathy patients were analyzed for phasing, single nucleotide variants, and structural variants. Variant phasing was successful in the large muscle genes studied. The longest continuous phase blocks were gained using high-quality DNA samples with long DNA fragments. Homozygosity increased the number of phase blocks, especially in exome sequencing samples lacking intronic variation. In our cohort, linked-read sequencing added more information about the structural variation but did not lead to a molecular genetic diagnosis. The linked-read technology can support the clinical diagnosis of neuromuscular and other genetic disorders.

Indexed as

Muscular DiseasesMyopathies, NemalineNeuromuscular DiseasesDNAHaplotypesHigh-Throughput Nucleotide SequencingHumansDNA

Identifiers

PMID38383731
PMCPMC10881483
OpenAlexW4392015409

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.